IL4R and Increased total eosinophil count: Our findings indicate that prophylactic treatment with IL-4Rα mAb not only reduced asthma phenotypes such as airway goblet cell metaplasia and eosinophilia, but also improved disease severity by reducing weight loss and viral load.